Method of preparing foot-and-mouth disease vaccine by using BHK-21 adherent cells

A technology for BHK-21 and foot-and-mouth disease vaccines, applied in the direction of microorganism-based methods, biochemical equipment and methods, microorganisms, etc., can solve the problems of increasing cultivation difficulties, pollution, consumption, large culture medium, etc., to improve the quantity and quality of antigens, Simplify the process flow and the effect of simple process flow

Active Publication Date: 2013-05-08
杭州国牧生物科技有限公司
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These 4-5 step-by-step scale-up steps need to consume a large amount of medium, which increases the difficulty of cultivation and the possibility of contamination. Each step of scale-up needs to cultivate cells for 3-4 days, so the period of the scale-up process is 15-20 days. , the whole production process cycle is 30-40 days

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] I. Cell Recovery and Primary Amplification

[0070] (1) Take out the BHK-21 cells frozen in liquid nitrogen, place them in a water bath at 37°C for recovery, and inoculate them into a 20ml square bottle (T-shaped bottle) containing 15% fetal bovine serum in DMEM medium, at 37 ℃, through 5% CO 2 for 2 days in a carbon dioxide incubator.

[0071] (2) The cell suspension obtained by cultivating in step (1) is digested by trypsin, and evenly distributed in 5 T-shaped bottles, and each bottle is supplemented with DMEM medium containing 10% fetal bovine serum to a total volume of 20ml , and continue to culture for 3 days by the conditions in (1).

[0072] (3) All the cells obtained after the culture in step (2) were digested with trypsin and collected.

[0073] (4) Cell count and viability were checked by trypan blue staining.

[0074] (5) The cell suspension obtained by cultivating in step (3) is digested by trypsin, and evenly distributed in 25 T-shaped bottles, and eac...

Embodiment 2

[0093] I. Cell Recovery and Primary Amplification

[0094] Same as described in Example 1.

[0095] Second, scale up the culture of cells

[0096] i. Debug and prepare the bioreactor according to the equipment instructions, perform necessary cleaning and sterilization steps, and conduct sterility tests to confirm that the bioreactor is in good production condition. Soak and sterilize the selected Cytodex1 microcarriers.

[0097] ii. DMEM medium was used as the base medium, and fetal calf serum was added to make the concentration 8%, which was used as the culture medium used in the scale-up culture. The culture fluid is injected into the bioreactor, and the microcarriers are added. Taking production in a 40L bioreactor as an example, inject 20 liters of medium, and add 750 grams of pretreated Cytodex1 microcarriers at a concentration of 25 grams per liter.

[0098] iii. Inoculate the cell suspension obtained as described in step 1 into a bioreactor, taking the production in...

Embodiment 3

[0108] I. Cell Recovery and Primary Amplification

[0109] (1) Take out the BHK-21 cells frozen in liquid nitrogen, place them in a water bath at 37°C for recovery, and inoculate them into a 20ml square bottle (T-shaped bottle) containing 15% fetal bovine serum in DMEM medium, at 37 ℃, through 5% CO 2 for 2 days in a carbon dioxide incubator.

[0110] (2) The cell suspension obtained by cultivating in step (1) is digested by trypsin, and evenly distributed in 5 T-shaped bottles, and each bottle is supplemented with DMEM medium containing 10% fetal bovine serum to a total volume of 20ml , and continue to culture for 3 days by the conditions in (1).

[0111] (3) All the cells obtained after the culture in step (2) were digested with trypsin and collected.

[0112] (4) Cell count and viability were checked by trypan blue staining.

[0113] (5) The cell suspension obtained by cultivating in step (3) is digested by trypsin, and evenly distributed in 25 T-shaped bottles, and eac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method of producing a foot-and-mouth disease vaccine by using a large-scale high-density BHK-21 cell adherent culture technology. The method comprises the following steps of: 1) thawing and primarily amplifying cells; 2) conducting large-scale and high-density cell culture in a medium-volume bioreactor, and after the culture is completed, diluting the high-density cell sap in a large cell culture pot; and 3) inoculating foot-and-mouth disease seed virus, harvesting all virus suspension under proper conditions, and preparing the foot-and-mouth disease vaccine through the following steps. The process method is free from the process of acclimating the adherent cells into suspension cells; the necessarily gradual amplification process in the existing technology of preparing the foot-and-mouth disease vaccine by conducting large-scale suspension culture of the BHK-21 cell can be avoided, the technology flow can be obviously simplified, the production cycle can be shortened, the escape of the foot-and-mouth disease virus can be furthest reduced, and the pollution possibility can be decreased.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals, and is specifically described as a method for preparing a foot-and-mouth disease vaccine by using BHK-21 cells in a bioreactor through one-step high-density large-scale adherent culture. Background technique [0002] Foot and mouth disease (FMD) is an acute, febrile, highly contagious infectious disease transmitted by artiodactyls caused by foot and mouth disease virus (FMDV), with more than 70 susceptible animals. Foot-and-mouth disease is highly contagious and can cause a decline in animal production performance. Once an outbreak occurs, it will cause huge economic losses to the animal husbandry in the infected area and seriously affect international trade. It is listed by the World Organization for Animal Health as an epidemic that must be reported as soon as possible. one of the diseases. [0003] FMDV belongs to the genus Aphthovirus of the family Picornaviridae, and has many serotypes, in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N7/00C12R1/93
Inventor 贾馨丹
Owner 杭州国牧生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products